[iito] Business Intelligence. (11/8/20). "The [LSUS] Newsletter Is Out! Hand-picked & Manually Edited Transatlantic Life Science Business News from Europe and North America". Bremen.

	Organisation	Fountain Healthcare Partners Fund III, L.P.
	Group	Fountain Healthcare Partners (IE)
	Organisation 2	TVM Life Science Innovation II L.P. (TVM LSI II)
	Group	TVM (Group)
	Product	LIFE SCIENCES
	Product 2	BIOTECH
	Index term	Emisphere–Novo Group: investment, 202011– acquisition of Emisphere by Novo Nordisk for $1.35b in cash on a cash/debt-free basis
	Index term 2	Horizon Discovery–PerkinElmer: investment, 202011– cash tender offer £296m ($383m) representing total enterprise value of £284m ($368m)
	Person	Cronin, Kate (Moderna 202107– Chief Brand Officer before Global CEO of Ogilvy Health)
	Person 2	Stephenson, James (Promethean Particles 202010– CEO before Carlisle Fluid Technologies + Polyone Corp + Dow Corning)

You can read the latest version of the [LSUS] Newsletter online at
https://www.life-sciences-europe.com/newsletter/lsus-newsletter-021011-asex.html

This issue features:

Novo Nordisk – Emisphere Technologies – PerkinElmer – Horizon Discovery – Sanofi – Kiadis Pharma – Fountain Healthcare Partners Fund III – Novartis – Vedere Bio – Definitive Healthcare – Monocl – Galecto – Nasdaq Global Market – Exact Sciences – Thrive Earlier – Base Genomics – Eagle Genomics – Prokarium – Ogilvy Health – Kate Cronin – Carl Wittwer – Scope Fluidics – Atbtherapeutics – Selexis – Promethean Particles – James Stephenson – TVM Capital Life Sciences Innovation II Fund – Eternygen – Evotec – Bayer – AskBio – CRISPR Therapeutics – MLM Medical Labs – MD Biosciences – Scorpion Therapeutics – Abcam – Atea – Roche – SparingVision – Stéphane Boissel – KBI Biopharma – Kynexis Medicine – NBE-Therapeutics – Vifor Pharma – Cara Tx – Immunic – European Investment Bank (EIB) – Cevec – Rznomics – Medigene – Cytovant – Rentschler Biopharma – ATUM – Regulatory and Quality Solutions (R&Q) – Maetrics – Exelixis

Record changed: 2023-06-05